{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:15:01Z","timestamp":1793315701860,"version":"4.5.0"},"reference-count":137,"publisher":"Springer Science and Business Media LLC","issue":"11-12","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T00:00:00Z","timestamp":1762300800000},"content-version":"vor","delay-in-days":4,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012819","name":"Egyptian Cultural and Educational Bureau","doi-asserted-by":"publisher","award":["MM42\/19"],"award-info":[{"award-number":["MM42\/19"]}],"id":[{"id":"10.13039\/100012819","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>The incidence of thyroid cancer, the most common endocrine malignancy, has increased by 313% in the past four decades and is now the seventh most common cancer worldwide. There is an urgent need for non-invasive diagnostic, prognostic, and surveillance biomarkers to improve patient outcomes. Given the promising role of extracellular vesicles (EVs) as liquid biopsy biomarkers, a systematic review of the literature was conducted to evaluate their diagnostic and prognostic utility in thyroid cancer. We also assessed the quality of included studies giving special emphasis to methodology, reporting standards, and adherence to MISEV2018 guidelines. A comprehensive search was conducted across Web of Science, Ovid Medline, Ovid Embase, Scopus, and Emcare for English-language studies published from inception to March 2025. Search terms included a combination of relevant keywords and subject Headings. A total of 40 studies met the inclusion criteria. Most focused on papillary thyroid carcinoma, with relatively a minority investigating follicular thyroid carcinoma. The majority examined small EVs (exosomes), with microRNAs (miRNAs) being the most studied EV biomarkers, followed by proteins, circular RNAs, long non-coding RNAs, mRNAs, DNA, procoagulant phospholipids, and biophysical characteristics. No studies investigated EV lipids or metabolites as potential thyroid cancer biomarkers. This systematic review highlights the strong potential of EVs as diagnostic and prognostic biomarkers in thyroid cancer. However, larger prospective patient cohorts are needed to validate current findings. Clinical translation will require standardised methodologies and robust comprehensive reporting aligned with MISEV2018 guidelines, enhancing reproducibility and paving the way for multicentre clinical trials.<\/jats:p>","DOI":"10.1007\/s00109-025-02594-1","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T23:10:44Z","timestamp":1762384244000},"page":"1333-1372","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["The diagnostic and prognostic potential of extracellular vesicles as biomarkers for thyroid cancer: a systematic review"],"prefix":"10.1007","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2849-9961","authenticated-orcid":false,"given":"Nada Mabrouk","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5824-5009","authenticated-orcid":false,"given":"Kevin","family":"Beatson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6877-0130","authenticated-orcid":false,"given":"Jigisha","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4582-0788","authenticated-orcid":false,"given":"Mohammad Mahmoud Rajab","family":"Eddama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7802-4481","authenticated-orcid":false,"given":"Lucie H.","family":"Clapp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7630-9985","authenticated-orcid":false,"given":"Tarek","family":"Abdel-Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,5]]},"reference":[{"issue":"3","key":"2594_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A (2024) Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 74(3):229\u2013263","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"2594_CR2","first-page":"394","volume":"68","author":"F Bray","year":"2018","unstructured":"Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394\u2013424","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"2594_CR3","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1001\/jama.2023.26348","volume":"331","author":"L Boucai","year":"2024","unstructured":"Boucai L, Zafereo M, Cabanillas ME (2024) Thyroid cancer: a review. JAMA 331(5):425\u2013435","journal-title":"JAMA"},{"issue":"1","key":"2594_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/thy.2015.0020","volume":"26","author":"BR Haugen","year":"2016","unstructured":"Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016a) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1\u2013133","journal-title":"Thyroid"},{"issue":"9","key":"2594_CR5","first-page":"1039","volume":"33","author":"SZ Ali","year":"2023","unstructured":"Ali SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, Vielh P, VanderLaan PA (2023) The 2023 Bethesda system for reporting thyroid cytopathology. Thyroid\u00ae 33(9):1039\u20131044","journal-title":"Thyroid\u00ae"},{"issue":"4","key":"2594_CR6","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1159\/000339959","volume":"56","author":"M Bongiovanni","year":"2012","unstructured":"Bongiovanni M, Spitale A, Faquin WC, Mazzucchelli L, Baloch ZW (2012) The Bethesda system for reporting thyroid cytopathology: a meta-analysis. Acta Cytol 56(4):333\u2013339","journal-title":"Acta Cytol"},{"key":"2594_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/cen.12515","volume":"81","author":"P Perros","year":"2014","unstructured":"Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G et al (2014) Guidelines for the management of thyroid cancer. Clin Endocrinol 81:1\u2013122","journal-title":"Clin Endocrinol"},{"issue":"7","key":"2594_CR8","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1089\/thy.2019.0140","volume":"30","author":"GA Jack","year":"2020","unstructured":"Jack GA, Sternberg SB, Aronson MD, Mukamal KJ, Oshin A, Hennessey JV (2020) Nondiagnostic fine-needle aspiration biopsy of thyroid nodules: outcomes and determinants. Thyroid 30(7):992\u2013998","journal-title":"Thyroid"},{"issue":"5","key":"2594_CR9","doi-asserted-by":"publisher","first-page":"107327481772923","DOI":"10.1177\/1073274817729231","volume":"24","author":"P Valderrabano","year":"2017","unstructured":"Valderrabano P, McIver B (2017) Evaluation and Management of Indeterminate Thyroid Nodules: the revolution of risk stratification beyond cytological diagnosis. Cancer Control 24(5):1073274817729231","journal-title":"Cancer Control"},{"issue":"2","key":"2594_CR10","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12022-022-09721-5","volume":"33","author":"U Mohan","year":"2022","unstructured":"Mohan U, Sunny SP, Mendonca P, Kuriakose MA, Kannan S, Suresh A (2022) Systematic review and Meta-analysis to identify the Immunocytochemical markers effective in delineating benign from malignant thyroid lesions in FNAC samples. Endocr Pathol 33(2):243\u2013256","journal-title":"Endocr Pathol"},{"issue":"3","key":"2594_CR11","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/cncy.21631","volume":"124","author":"WC Faquin","year":"2016","unstructured":"Faquin WC, Wong LQ, Afrogheh AH, Ali SZ, Bishop JA, Bongiovanni M et al (2016) Impact of reclassifying noninvasive follicular variant of papillary thyroid carcinoma on the risk of malignancy in the Bethesda system for reporting thyroid cytopathology. Cancer Cytopathol 124(3):181\u2013187","journal-title":"Cancer Cytopathol"},{"issue":"1","key":"2594_CR12","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1159\/000345498","volume":"75","author":"E Kandil","year":"2013","unstructured":"Kandil E, Krishnan B, Noureldine SI, Yao L, Tufano RP (2013a) Hemithyroidectomy: a meta-analysis of postoperative need for hormone replacement and complications. Orl 75(1):6\u201317","journal-title":"Orl"},{"issue":"3","key":"2594_CR13","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1097\/SLA.0000000000003580","volume":"271","author":"KN Patel","year":"2020","unstructured":"Patel KN, Yip L, Lubitz CC, Grubbs EG, Miller BS, Shen W et al (2020) The American Association of Endocrine Surgeons Guidelines for the definitive surgical Management of Thyroid Disease in adults. Ann Surg 271(3):e21\u2013e93","journal-title":"Ann Surg"},{"issue":"2","key":"2594_CR14","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1001\/jamaoto.2021.3387","volume":"148","author":"M Alabousi","year":"2022","unstructured":"Alabousi M, Alabousi A, Adham S, Pozdnyakov A, Ramadan S, Chaudhari H et al (2022) Diagnostic test accuracy of ultrasonography vs computed tomography for papillary thyroid Cancer cervical lymph node metastasis: a systematic review and Meta-analysis. JAMA Otolaryngol Head Neck Surg 148(2):107\u2013118","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"key":"2594_CR15","doi-asserted-by":"publisher","unstructured":"Ritter A, Mizrachi A, Bachar G, Vainer I, Shimon I, Hirsch D et al (2020) Detecting recurrence following lobectomy for thyroid Cancer: role of thyroglobulin and thyroglobulin antibodies. J Clin Endocrinol Metab 105(6):dgaa152. https:\/\/doi.org\/10.1210\/clinem\/dgaa152","DOI":"10.1210\/clinem\/dgaa152"},{"issue":"2","key":"2594_CR16","doi-asserted-by":"publisher","first-page":"R11","DOI":"10.1093\/ejendo\/lvad109","volume":"189","author":"L Giovanella","year":"2023","unstructured":"Giovanella L, D'Aurizio F, Algeciras-Schimnich A, G\u00f6rges R, Petranovic Ovcaricek P, Tuttle RM et al (2023) Thyroglobulin and thyroglobulin antibody: an updated clinical and laboratory expert consensus. Eur J Endocrinol 189(2):R11\u2013r27","journal-title":"Eur J Endocrinol"},{"issue":"3","key":"2594_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.tips.2019.01.006","volume":"40","author":"G De Rubis","year":"2019","unstructured":"De Rubis G, Rajeev Krishnan S, Bebawy M (2019) Liquid biopsies in Cancer diagnosis, monitoring, and prognosis. Trends Pharmacol Sci 40(3):172\u2013186","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"2594_CR18","doi-asserted-by":"publisher","first-page":"1535750","DOI":"10.1080\/20013078.2018.1535750","volume":"7","author":"C Th\u00e9ry","year":"2018","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R et al (2018) Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J Extracell Vesicles 7(1):1535750","journal-title":"J Extracell Vesicles"},{"key":"2594_CR19","doi-asserted-by":"publisher","first-page":"28414","DOI":"10.3402\/jev.v4.28414","volume":"4","author":"A Piccin","year":"2015","unstructured":"Piccin A, Murphy C, Eakins E, Kunde J, Corvetta D, Di Pierro A et al (2015) Circulating microparticles, protein C, free protein S and endothelial vascular markers in children with sickle cell anaemia. J Extracell Vesicles 4:28414","journal-title":"J Extracell Vesicles"},{"key":"2594_CR20","doi-asserted-by":"crossref","unstructured":"Chuo ST-Y, Chien JC-Y, Lai CP-K (2018) Imaging extracellular vesicles: current and emerging methods. J Biomed Sci 25(1):91","DOI":"10.1186\/s12929-018-0494-5"},{"key":"2594_CR21","doi-asserted-by":"publisher","unstructured":"Kurtjak M, Kere\u00efche S, Klepac D, Kri\u017ean H, Per\u010di\u0107 M, Kru\u0161i\u0107 Ali\u0107 V et al (2022) Unveiling the native morphology of extracellular vesicles from human cerebrospinal fluid by atomic force and cryogenic Electron microscopy. Biomedicines 10(6):251. https:\/\/doi.org\/10.3390\/biomedicines10061251","DOI":"10.3390\/biomedicines10061251"},{"key":"2594_CR22","doi-asserted-by":"publisher","unstructured":"Elzanowska J, Semira C, Costa-Silva B (2020) DNA in extracellular vesicles: biological and clinical aspects. Mol Oncol 15(6):1701\u20131714. https:\/\/doi.org\/10.1002\/1878-0261.12777","DOI":"10.1002\/1878-0261.12777"},{"issue":"12","key":"2594_CR23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1001450","volume":"10","author":"H Kalra","year":"2012","unstructured":"Kalra H, Simpson RJ, Ji H, Aikawa E, Altevogt P, Askenase P et al (2012) Vesiclepedia: a compendium for extracellular vesicles with continuous community annotation. PLoS Biol 10(12):e1001450","journal-title":"PLoS Biol"},{"issue":"1","key":"2594_CR24","doi-asserted-by":"publisher","first-page":"4389","DOI":"10.1038\/s41467-021-24384-2","volume":"12","author":"M Mathieu","year":"2021","unstructured":"Mathieu M, N\u00e9vo N, Jouve M, Valenzuela JI, Maurin M, Verweij FJ et al (2021) Specificities of exosome versus small ectosome secretion revealed by live intracellular tracking of CD63 and CD9. Nat Commun 12(1):4389","journal-title":"Nat Commun"},{"issue":"2","key":"2594_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12404","volume":"13","author":"JA Welsh","year":"2024","unstructured":"Welsh JA, Goberdhan DCI, O'Driscoll L, Buzas EI, Blenkiron C, Bussolati B et al (2024) Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches. J Extracell Vesicles 13(2):e12404","journal-title":"J Extracell Vesicles"},{"issue":"39","key":"2594_CR26","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2303077120","volume":"120","author":"IA Hatton","year":"2023","unstructured":"Hatton IA, Galbraith ED, Merleau NSC, Miettinen TP, Smith BM, Shander JA (2023) The human cell count and size distribution. Proc Natl Acad Sci USA 120(39):e2303077120","journal-title":"Proc Natl Acad Sci USA"},{"issue":"2","key":"2594_CR27","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1159\/000491898","volume":"48","author":"ZL Qiu","year":"2018","unstructured":"Qiu ZL, Wei WJ, Sun ZK, Shen CT, Song HJ, Zhang XY et al (2018) Circulating tumor cells correlate with Clinicopathological features and outcomes in differentiated thyroid Cancer. Cell Physiol Biochem 48(2):718\u2013730","journal-title":"Cell Physiol Biochem"},{"key":"2594_CR28","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.mam.2017.11.009","volume":"60","author":"N Garcia-Romero","year":"2018","unstructured":"Garcia-Romero N, Esteban-Rubio S, Rackov G, Carri\u00f3n-Navarro J, Belda-Iniesta C, Ayuso-Sacido A (2018) Extracellular vesicles compartment in liquid biopsies: Clinical application. Mol Asp Med 60:27\u201337","journal-title":"Mol Asp Med"},{"issue":"8","key":"2594_CR29","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1016\/j.cell.2023.03.010","volume":"186","author":"R Kalluri","year":"2023","unstructured":"Kalluri R, McAndrews KM (2023) The role of extracellular vesicles in cancer. Cell 186(8):1610\u20131626","journal-title":"Cell"},{"key":"2594_CR30","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD et al (2021) The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 372:n71","journal-title":"BMJ"},{"issue":"1","key":"2594_CR31","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A (2016) Rayyan-a web and mobile app for systematic reviews. Syst Rev 5(1):210","journal-title":"Syst Rev"},{"issue":"8","key":"2594_CR32","doi-asserted-by":"publisher","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","volume":"155","author":"PF Whiting","year":"2011","unstructured":"Whiting PF, Rutjes AW, Westwood ME, Mallett S, Deeks JJ, Reitsma JB et al (2011) QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies. Ann Intern Med 155(8):529\u2013536","journal-title":"Ann Intern Med"},{"issue":"4","key":"2594_CR33","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1530\/ERC-14-0077","volume":"21","author":"M Boufraqech","year":"2014","unstructured":"Boufraqech M, Zhang L, Jain M, Patel D, Ellis R, Xiong Y et al (2014a) miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3. Endocr Relat Cancer 21(4):517\u2013531","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"2594_CR34","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/s12020-021-02847-2","volume":"75","author":"F Capriglione","year":"2022","unstructured":"Capriglione F, Verrienti A, Celano M, Maggisano V, Sponziello M, Pecce V et al (2022) Analysis of serum microRNA in exosomal vehicles of papillary thyroid cancer. Endocrine 75(1):185\u2013193","journal-title":"Endocrine"},{"issue":"3","key":"2594_CR35","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1007\/s12020-021-02949-x","volume":"75","author":"W Chen","year":"2022","unstructured":"Chen W, Li G, Li Z, Zhu J, Wei T, Lei J (2022) Evaluation of plasma exosomal miRNAs as potential diagnostic biomarkers of lymph node metastasis in papillary thyroid carcinoma. Endocrine 75(3):846\u2013855","journal-title":"Endocrine"},{"issue":"5","key":"2594_CR36","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1530\/ERC-19-0008","volume":"26","author":"F Wu","year":"2019","unstructured":"Wu F, Li F, Lin X, Xu F, Cui RR, Zhong JY et al (2019) Exosomes increased angiogenesis in papillary thyroid cancer microenvironment. Endocr Relat Cancer 26(5):525\u2013538","journal-title":"Endocr Relat Cancer"},{"key":"2594_CR37","doi-asserted-by":"publisher","unstructured":"Zabegina L, Nazarova I, Knyazeva M, Nikiforova N, Slyusarenko M, Titov S et al (2020) MiRNA let-7 from TPO(+) extracellular vesicles is a potential marker for a differential diagnosis of follicular thyroid nodules. Cells 9(8):1917. https:\/\/doi.org\/10.3390\/cells9081917","DOI":"10.3390\/cells9081917"},{"issue":"7","key":"2594_CR38","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1530\/ERC-21-0343","volume":"29","author":"O Delcorte","year":"2022","unstructured":"Delcorte O, Craps J, Mahibullah S, Spourquet C, D'Auria L, Van Der Smissen P et al (2022) Two miRNAs enriched in plasma extracellular vesicles are potential biomarkers for thyroid cancer. Endocr Relat Cancer 29(7):389\u2013401","journal-title":"Endocr Relat Cancer"},{"key":"2594_CR39","doi-asserted-by":"publisher","unstructured":"Li G, Chen W, Gong Y, Wei T, Gong R, Zhu J et al (2022) Identification of circulating Exosomal microRNAs associated with radioiodine refractory in papillary thyroid carcinoma. J Pers Med 12(12):2017. https:\/\/doi.org\/10.3390\/jpm12122017","DOI":"10.3390\/jpm12122017"},{"issue":"4","key":"2594_CR40","first-page":"773","volume":"69","author":"L Qiao","year":"2022","unstructured":"Qiao L, Dong C, Jia W, Ma B (2022) Exosomal miR-655-3p inhibits growth, and invasion and macrophage M2 polarization through targeting CXCR4 in papillary thyroid carcinoma. Acta Biochim Pol 69(4):773\u2013779","journal-title":"Acta Biochim Pol"},{"issue":"5","key":"2594_CR41","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2174\/1386207324666210125110732","volume":"25","author":"Y Xin","year":"2022","unstructured":"Xin Y, Meng K, Guo H, Chen B, Zheng C, Shou X, Yu K (2022) Exosomal hsa-miR-129-2 and hsa-miR-889 from a 6-microRNA signature might be a potential biomarker for predicting the prognosis of papillary thyroid carcinoma. Comb Chem High Throughput Screen 25(5):819\u2013830","journal-title":"Comb Chem High Throughput Screen"},{"issue":"1","key":"2594_CR42","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23560","volume":"35","author":"Q Wen","year":"2021","unstructured":"Wen Q, Wang Y, Li X, Jin X, Wang G (2021a) Decreased serum exosomal miR-29a expression and its clinical significance in papillary thyroid carcinoma. J Clin Lab Anal 35(1):e23560","journal-title":"J Clin Lab Anal"},{"issue":"21","key":"2594_CR43","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1097\/CM9.0000000000001107","volume":"133","author":"X Zou","year":"2020","unstructured":"Zou X, Gao F, Wang ZY, Zhang H, Liu QX, Jiang L et al (2020a) A three-microRNA panel in serum as novel biomarker for papillary thyroid carcinoma diagnosis. Chin Med J 133(21):2543\u20132551","journal-title":"Chin Med J"},{"issue":"1","key":"2594_CR44","first-page":"18","volume":"41","author":"Q Pan","year":"2020","unstructured":"Pan Q, Zhao J, Li M, Liu X, Xu Y, Li W et al (2020) Exosomal miRNAs are potential diagnostic biomarkers between malignant and benign thyroid nodules based on next-generation sequencing. Carcinogenesis 41(1):18\u201324","journal-title":"Carcinogenesis"},{"key":"2594_CR45","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3389\/fgene.2020.00449","volume":"11","author":"M Liang","year":"2020","unstructured":"Liang M, Yu S, Tang S, Bai L, Cheng J, Gu Y et al (2020) A panel of plasma Exosomal miRNAs as potential biomarkers for differential diagnosis of thyroid nodules. Front Genet 11:449","journal-title":"Front Genet"},{"key":"2594_CR46","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.2147\/OTT.S231361","volume":"13","author":"K Jiang","year":"2020","unstructured":"Jiang K, Li G, Chen W, Song L, Wei T, Li Z et al (2020) Plasma exosomal miR-146b-5p and miR-222-3p are potential biomarkers for lymph node metastasis in papillary thyroid carcinomas. Onco Targets Ther 13:1311\u20131319. https:\/\/doi.org\/10.2147\/OTT.S231361","journal-title":"Onco Targets Ther"},{"issue":"1","key":"2594_CR47","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1530\/EJE-19-0524","volume":"182","author":"D Dai","year":"2020","unstructured":"Dai D, Tan Y, Guo L, Tang A, Zhao Y (2020a) Identification of exosomal miRNA biomarkers for diagnosis of papillary thyroid cancer by small RNA sequencing. Eur J Endocrinol 182(1):111\u2013121","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"2594_CR48","doi-asserted-by":"publisher","first-page":"516","DOI":"10.4149\/neo_2018_180824N643","volume":"66","author":"W Ye","year":"2019","unstructured":"Ye W, Deng X, Fan Y (2019) Exosomal miRNA423-5p mediated oncogene activity in papillary thyroid carcinoma: a potential diagnostic and biological target for cancer therapy. Neoplasma 66(4):516\u2013523","journal-title":"Neoplasma"},{"key":"2594_CR49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.gene.2019.01.016","volume":"693","author":"Z Wang","year":"2019","unstructured":"Wang Z, Lv J, Zou X, Huang Z, Zhang H, Liu Q et al (2019a) A three plasma microRNA signature for papillary thyroid carcinoma diagnosis in Chinese patients. Gene 693:37\u201345","journal-title":"Gene"},{"issue":"9","key":"2594_CR50","doi-asserted-by":"publisher","first-page":"12011","DOI":"10.1007\/s13277-016-5065-3","volume":"37","author":"R Samsonov","year":"2016","unstructured":"Samsonov R, Burdakov V, Shtam T, Radzhabov\u0430 Z, Vasilyev D, Tsyrlina E et al (2016) Plasma exosomal miR-21 and miR-181a differentiates follicular from papillary thyroid cancer. Tumour Biol 37(9):12011\u201312021","journal-title":"Tumour Biol"},{"issue":"6","key":"2594_CR51","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1038\/s41416-024-02575-0","volume":"130","author":"G Li","year":"2024","unstructured":"Li G, Wang H, Zhong J, Bai Y, Chen W, Jiang K et al (2024a) Circulating small extracellular vesicle-based miRNA classifier for follicular thyroid carcinoma: a diagnostic study. Br J Cancer 130(6):925\u2013933","journal-title":"Br J Cancer"},{"key":"2594_CR52","doi-asserted-by":"publisher","unstructured":"Haigh T, Beattie H, Wade MA, England J, Kuvshinov D, Karsai L et al (2023) The use of tissue-on-Chip Technology to focus the search for extracellular vesicle miRNA biomarkers in thyroid disease. Int J Mol Sci 25(1):71. https:\/\/doi.org\/10.3390\/ijms25010071","DOI":"10.3390\/ijms25010071"},{"key":"2594_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.aca.2024.342792","volume":"1314","author":"Y Gao","year":"2024","unstructured":"Gao Y, Wang P, Liang Z, Li Z, Li W, Ma Q (2024) The ECL enhancement of MBene QDs with nanoparticle-on-mirror structure for sensitive detection of exosomal miRNA. Anal Chim Acta 1314:342792","journal-title":"Anal Chim Acta"},{"key":"2594_CR54","doi-asserted-by":"publisher","unstructured":"D'Amico G, Santonocito R, Grech G, Graceffa G, Cipolla C, Scalia F et al (2024) MiRNAs in extracellular vesicles as biomarkers in plasma of papillary thyroid Cancer patients: a proof-of-concept study. Biology (Basel) 13(9):743. https:\/\/doi.org\/10.3390\/biology13090743","DOI":"10.3390\/biology13090743"},{"key":"2594_CR55","doi-asserted-by":"publisher","unstructured":"Ahmed NM, Eddama MMR, Beatson K, Gurung R, Patel J, Iskandar G et al (2024) Circulating large extracellular vesicles as diagnostic biomarkers of indeterminate thyroid nodules: multi-platform omics analysis. BJS Open 9(1):zrae139. https:\/\/doi.org\/10.1093\/bjsopen\/zrae139","DOI":"10.1093\/bjsopen\/zrae139"},{"key":"2594_CR56","unstructured":"Baciu AE, Uyy E, Suica VI, Boteanu RM, Popescu AI, Giulea C et al (2017) Proteomic analysis of plasma molecular markers as predictors of differentiated thyroid cancer. Rom Rep Phys 2017;69(1):601"},{"issue":"18","key":"2594_CR57","doi-asserted-by":"publisher","first-page":"4496","DOI":"10.3390\/ijms20184496","volume":"20","author":"CC Bavisotto","year":"2019","unstructured":"Bavisotto CC, Cipolla C, Graceffa G, Barone R, Bucchieri F, Bulone D et al (2019) Immunomorphological pattern of molecular chaperones in normal and pathological thyroid tissues and circulating exosomes: potential use in clinics. Int J Mol Sci 20(18):4496","journal-title":"Int J Mol Sci"},{"key":"2594_CR58","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fendo.2020.00382","volume":"11","author":"TY Huang","year":"2020","unstructured":"Huang TY, Wang CY, Chen KY, Huang LT (2020a) Urinary Exosomal thyroglobulin in thyroid Cancer patients with post-ablative therapy: a new biomarker in thyroid Cancer. Front Endocrinol 11:382","journal-title":"Front Endocrinol"},{"issue":"10","key":"2594_CR59","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1530\/ERC-17-0547","volume":"25","author":"D Luo","year":"2018","unstructured":"Luo D, Zhan S, Xia W, Huang L, Ge W, Wang T (2018) Proteomics study of serum exosomes from papillary thyroid cancer patients. Endocr Relat Cancer 25(10):879\u2013891","journal-title":"Endocr Relat Cancer"},{"key":"2594_CR60","doi-asserted-by":"publisher","unstructured":"Wang G, He L, Wang S, Zhang M, Li Y, Liu Q et al (2020) EV PD-L1 is correlated with clinical features and contributes to T cell suppression in pediatric thyroid cancer. J Clin Endocrinol Metab 105(8):dgaa309. https:\/\/doi.org\/10.1210\/clinem\/dgaa309","DOI":"10.1210\/clinem\/dgaa309"},{"key":"2594_CR61","doi-asserted-by":"publisher","unstructured":"Wang CY, Shih SR, Chen KY, Huang PJ (2022) Urinary exosomal tissue TIMP and angiopoietin-1 are preoperative novel biomarkers of well-differentiated thyroid cancer. Biomedicines 11(1):24. https:\/\/doi.org\/10.3390\/biomedicines11010024","DOI":"10.3390\/biomedicines11010024"},{"key":"2594_CR62","doi-asserted-by":"publisher","first-page":"4667","DOI":"10.2147\/IJN.S458931","volume":"19","author":"CY Wang","year":"2024","unstructured":"Wang CY, Shih SR, Chen KY, Chung YC, Huang PJ (2024) Long-term changes of urinary Exosomal peptide levels after thyroidectomy in patients with thyroid Cancer: a prospective observational study. Int J Nanomedicine 19:4667\u20134677","journal-title":"Int J Nanomedicine"},{"key":"2594_CR63","doi-asserted-by":"publisher","unstructured":"Cao Z, Wang Y, Wu J, Tang X, Qian Z, Zhang Z et al (2024) Serum small extracellular vesicles-derived BST2 as a biomarker for papillary thyroid microcarcinoma promotes lymph node metastasis. Cancer Gene Ther 32:38\u201350. https:\/\/doi.org\/10.1038\/s41417-024-00854-9","DOI":"10.1038\/s41417-024-00854-9"},{"key":"2594_CR64","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.12659\/MSM.915658","volume":"25","author":"C Yang","year":"2019","unstructured":"Yang C, Wei Y, Yu L, Xiao Y (2019) Identification of altered circular RNA expression in serum exosomes from patients with papillary thyroid carcinoma by high-throughput sequencing. Med Sci Monit 25:2785\u20132791","journal-title":"Med Sci Monit"},{"issue":"2","key":"2594_CR65","doi-asserted-by":"publisher","first-page":"10136","DOI":"10.1080\/21655979.2021.2000745","volume":"12","author":"Q Lin","year":"2021","unstructured":"Lin Q, Qi Q, Hou S, Chen Z, Jiang N, Zhang L, Lin C (2021) Exosomal circular RNA hsa_circ_007293 promotes proliferation, migration, invasion, and epithelial-mesenchymal transition of papillary thyroid carcinoma cells through regulation of the microRNA-653-5p\/paired box 6 axis. Bioengineered 12(2):10136\u201310149","journal-title":"Bioengineered"},{"key":"2594_CR66","doi-asserted-by":"publisher","unstructured":"Dai L, Hu W, Jiang H, Wang Y, Le Q, Wu X, Meng X (2023a) The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer. Int J Clin Oncol 28(11):1461\u20131474. https:\/\/doi.org\/10.1007\/s10147-023-02400-3","DOI":"10.1007\/s10147-023-02400-3"},{"key":"2594_CR67","doi-asserted-by":"crossref","unstructured":"Peng H, Zhu Z, Xing J, Xu Q, Man C, Wang S et al (2024) Expression profiling and bioinformatics analysis of serum exosomal circular RNAs in lymph node metastasis of papillary thyroid carcinoma. J Biomed Res:1\u201315","DOI":"10.7555\/JBR.37.20230304"},{"issue":"9","key":"2594_CR68","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/s41419-020-02827-w","volume":"11","author":"W Dai","year":"2020","unstructured":"Dai W, Jin X, Han L, Huang H, Ji Z, Xu X et al (2020b) Exosomal lncRNA DOCK9-AS2 derived from cancer stem cell-like cells activated Wnt\/\u03b2-catenin pathway to aggravate stemness, proliferation, migration, and invasion in papillary thyroid carcinoma. Cell Death Dis 11(9):743","journal-title":"Cell Death Dis"},{"key":"2594_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.nantod.2024.102431","volume":"58","author":"B Feng","year":"2024","unstructured":"Feng B, Wang J, Zhang RY, Wei AY, Zhao C, Yen Y-T et al (2024) Click chemistry-mediated enrichment of circulating tumor cells and tumor-derived extracellular vesicles for dual liquid biopsy in differentiated thyroid cancer. Nano Today 58:102431","journal-title":"Nano Today"},{"key":"2594_CR70","doi-asserted-by":"publisher","unstructured":"Li S, Li H, Wang P, Ma Q (2024b) Eu-doped chitosan carbon dot\/dendritic silver nanostructure-based biosensor for BRAF detection in thyroid cancer exosome. Microchem J. https:\/\/doi.org\/10.1016\/j.microc.2024.110966","DOI":"10.1016\/j.microc.2024.110966"},{"issue":"7","key":"2594_CR71","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1097\/MBC.0b013e32832c5e51","volume":"20","author":"P van Dreden","year":"2009","unstructured":"van Dreden P, Rousseau A, Fontaine S, Woodhams BJ, Exner T (2009a) Clinical evaluation of a new functional test for detection of plasma procoagulant phospholipids. Blood Coagul Fibrinolysis 20(7):494\u2013502","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2594_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.cej.2024.150835","volume":"488","author":"X Sun","year":"2024","unstructured":"Sun X, Chen B, Li Z, Shan Y, Jian M, Meng X, Wang Z (2024) Accurate diagnosis of thyroid cancer using a combination of surface-enhanced Raman spectroscopy of exosome on MXene-coated gold@silver core@shell nanoparticle substrate and deep learning. Chem Eng J 488:150835","journal-title":"Chem Eng J"},{"key":"2594_CR73","doi-asserted-by":"crossref","unstructured":"Karlsson M, Zhang C, M\u00e9ar L, Zhong W, Digre A, Katona B et al (2021) A single-cell type transcriptomics map of human tissues. Sci Adv 7(31) Human Protein Atlas proteinatlas.org","DOI":"10.1126\/sciadv.abh2169"},{"issue":"3","key":"2594_CR74","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nmeth.4185","volume":"14","author":"J Van Deun","year":"2017","unstructured":"Van Deun J, Mestdagh P, Agostinis P, Akay \u00d6, Anand S, Anckaert J et al (2017) EV-TRACK: transparent reporting and centralizing knowledge in extracellular vesicle research. Nat Methods 14(3):228\u2013232","journal-title":"Nat Methods"},{"key":"2594_CR75","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/978-1-0716-0759-6_10","volume":"2174","author":"WH Chang","year":"2021","unstructured":"Chang WH, Cerione RA, Antonyak MA (2021) Extracellular Vesicles and their roles in Cancer progression. Methods Mol Biol 2174:143\u2013170","journal-title":"Methods Mol Biol"},{"issue":"7","key":"2594_CR76","doi-asserted-by":"publisher","first-page":"537","DOI":"10.2174\/138920210793175895","volume":"11","author":"LA Macfarlane","year":"2010","unstructured":"Macfarlane LA, Murphy PR (2010) MicroRNA: biogenesis, function and role in Cancer. Curr Genomics 11(7):537\u2013561","journal-title":"Curr Genomics"},{"key":"2594_CR77","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.620498","volume":"9","author":"M Prieto-Vila","year":"2021","unstructured":"Prieto-Vila M, Yoshioka Y, Ochiya T (2021) Biological functions driven by mRNAs carried by extracellular vesicles in Cancer. Front Cell Dev Biol 9:620498","journal-title":"Front Cell Dev Biol"},{"issue":"2","key":"2594_CR78","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s10555-023-10147-6","volume":"43","author":"Z Ye","year":"2024","unstructured":"Ye Z, Chen W, Li G, Huang J, Lei J (2024) Tissue-derived extracellular vesicles in cancer progression: mechanisms, roles, and potential applications. Cancer Metastasis Rev 43(2):575\u2013595","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"2594_CR79","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12885-018-4006-5","volume":"18","author":"T Goto","year":"2018","unstructured":"Goto T, Fujiya M, Konishi H, Sasajima J, Fujibayashi S, Hayashi A et al (2018) An elevated expression of serum exosomal microRNA-191, \u2212\u200921, \u2212451a of pancreatic neoplasm is considered to be efficient diagnostic marker. BMC Cancer 18(1):116","journal-title":"BMC Cancer"},{"issue":"5","key":"2594_CR80","doi-asserted-by":"publisher","first-page":"1252","DOI":"10.1053\/j.gastro.2022.06.090","volume":"163","author":"K Nakamura","year":"2022","unstructured":"Nakamura K, Zhu Z, Roy S, Jun E, Han H, Munoz RM et al (2022) An exosome-based transcriptomic signature for noninvasive, early detection of patients with pancreatic ductal adenocarcinoma: a multicenter cohort study. Gastroenterology 163(5):1252\u201366.e2","journal-title":"Gastroenterology"},{"key":"2594_CR81","doi-asserted-by":"publisher","unstructured":"Toraih EA, Elshazli RM, Trinh LN, Hussein MH, Attia AA, Ruiz EML et al (2021) Diagnostic and prognostic performance of liquid biopsy-derived Exosomal MicroRNAs in thyroid Cancer patients: a systematic review and Meta-analysis. Cancers (Basel) 13(17):4295. https:\/\/doi.org\/10.3390\/cancers13174295","DOI":"10.3390\/cancers13174295"},{"issue":"1","key":"2594_CR82","doi-asserted-by":"publisher","DOI":"10.1002\/jcla.23560","volume":"35","author":"Q Wen","year":"2021","unstructured":"Wen Q, Wang Y, Li X, Jin X, Wang G (2021b) Decreased serum exosomal miR-29a expression and its clinical significance in papillary thyroid carcinoma. J Clin Lab Anal 35(1):e23560","journal-title":"J Clin Lab Anal"},{"issue":"22","key":"2594_CR83","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1016\/j.cub.2009.09.059","volume":"19","author":"V Muralidharan-Chari","year":"2009","unstructured":"Muralidharan-Chari V, Clancy J, Plou C, Romao M, Chavrier P, Raposo G, D'Souza-Schorey C (2009) ARF6-regulated shedding of tumor cell-derived plasma membrane microvesicles. Curr Biol 19(22):1875\u20131885","journal-title":"Curr Biol"},{"key":"2594_CR84","doi-asserted-by":"publisher","first-page":"911861","DOI":"10.3389\/fmed.2022.911861","volume":"9","author":"X Dai","year":"2022","unstructured":"Dai X, Shen L (2022a) Advances and trends in omics technology development. Front Med 9:911861","journal-title":"Front Med"},{"issue":"3","key":"2594_CR85","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1576\/toag.13.3.189.27672","volume":"13","author":"RP Horgan","year":"2011","unstructured":"Horgan RP, Kenny LC (2011) \u2018Omic\u2019 technologies: genomics, transcriptomics, proteomics and metabolomics. Obstet Gynaecol 13(3):189\u2013195","journal-title":"Obstet Gynaecol"},{"issue":"1","key":"2594_CR86","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/s12943-019-1041-z","volume":"18","author":"Y Wang","year":"2019","unstructured":"Wang Y, Liu J, Ma J, Sun T, Zhou Q, Wang W et al (2019b) Exosomal circRNAs: biogenesis, effect and application in human diseases. Mol Cancer 18(1):116","journal-title":"Mol Cancer"},{"issue":"1","key":"2594_CR87","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1038\/s42003-022-04262-3","volume":"5","author":"L Ren","year":"2022","unstructured":"Ren L, Jiang Q, Mo L, Tan L, Dong Q, Meng L et al (2022) Mechanisms of circular RNA degradation. Commun Biol 5(1):1355","journal-title":"Commun Biol"},{"issue":"11","key":"2594_CR88","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1007\/s10147-023-02400-3","volume":"28","author":"L Dai","year":"2023","unstructured":"Dai L, Hu W, Jiang H, Wang Y, Le Q, Wu X, Meng X (2023b) The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer. Int J Clin Oncol 28(11):1461\u20131474. https:\/\/doi.org\/10.1007\/s10147-023-02400-3","journal-title":"Int J Clin Oncol"},{"issue":"1","key":"2594_CR89","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1186\/s12943-020-01286-3","volume":"19","author":"W-Y Zhou","year":"2020","unstructured":"Zhou W-Y, Cai Z-R, Liu J, Wang D-S, Ju H-Q, Xu R-H (2020) Circular RNA: metabolism, functions and interactions with proteins. Mol Cancer 19(1):172","journal-title":"Mol Cancer"},{"key":"2594_CR90","doi-asserted-by":"publisher","unstructured":"Zhu G, Chang X, Kang Y, Zhao X, Tang X, Ma C, Fu S (2021a) CircRNA: a novel potential strategy to treat thyroid cancer (review). Int J Mol Med 48(5):201. https:\/\/doi.org\/10.3892\/ijmm.2021.5034","DOI":"10.3892\/ijmm.2021.5034"},{"issue":"2","key":"2594_CR91","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/s41580-020-00315-9","volume":"22","author":"L Statello","year":"2021","unstructured":"Statello L, Guo CJ, Chen LL, Huarte M (2021) Gene regulation by long non-coding RNAs and its biological functions. Nat Rev Mol Cell Biol 22(2):96\u2013118","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2594_CR92","first-page":"33","volume-title":"International review of cell and molecular biology","author":"CH Li","year":"2016","unstructured":"Li CH, Chen Y (2016) Chapter two - insight into the role of long noncoding rna in cancer development and progression. In: Jeon KW, Galluzzi L (eds) International review of cell and molecular biology, vol 326. Academic Press, pp 33\u201365"},{"key":"2594_CR93","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3389\/fonc.2020.00941","volume":"10","author":"X Peng","year":"2020","unstructured":"Peng X, Zhang K, Ma L, Xu J, Chang W (2020) The role of long non-coding RNAs in thyroid Cancer. Front Oncol 10:941","journal-title":"Front Oncol"},{"key":"2594_CR94","doi-asserted-by":"publisher","unstructured":"Doyle LM, Wang MZ (2019) Overview of extracellular vesicles, their origin, composition, purpose, and methods for exosome isolation and analysis. Cells 8(7):727. https:\/\/doi.org\/10.3390\/cells8070727","DOI":"10.3390\/cells8070727"},{"issue":"11","key":"2594_CR95","doi-asserted-by":"publisher","first-page":"3791","DOI":"10.1182\/blood.V94.11.3791","volume":"94","author":"HF Heijnen","year":"1999","unstructured":"Heijnen HF, Schiel AE, Fijnheer R, Geuze HJ, Sixma JJ (1999) Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 94(11):3791\u20133799","journal-title":"Blood"},{"key":"2594_CR96","doi-asserted-by":"publisher","first-page":"7071","DOI":"10.2147\/IJN.S325448","volume":"16","author":"S Zhu","year":"2021","unstructured":"Zhu S, Li S, Yi M, Li N, Wu K (2021b) Roles of microvesicles in tumor progression and clinical applications. Int J Nanomedicine 16:7071\u20137090","journal-title":"Int J Nanomedicine"},{"issue":"2","key":"2594_CR97","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1379\/CSC-99r.1","volume":"10","author":"DR Ciocca","year":"2005","unstructured":"Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10(2):86\u2013103","journal-title":"Cell Stress Chaperones"},{"issue":"7718","key":"2594_CR98","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1038\/s41586-018-0392-8","volume":"560","author":"G Chen","year":"2018","unstructured":"Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W et al (2018) Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature 560(7718):382\u2013386","journal-title":"Nature"},{"issue":"6332","key":"2594_CR99","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1126\/science.aaf1292","volume":"355","author":"E Hui","year":"2017","unstructured":"Hui E, Cheung J, Zhu J, Su X, Taylor MJ, Wallweber HA et al (2017) T cell costimulatory receptor CD28 is a primary target for PD-1-mediated inhibition. Science 355(6332):1428\u20131433","journal-title":"Science"},{"key":"2594_CR100","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.2147\/OTT.S105862","volume":"9","author":"X Wang","year":"2016","unstructured":"Wang X, Teng F, Kong L, Yu J (2016) PD-L1 expression in human cancers and its association with clinical outcomes. Onco Targets Ther 9:5023\u20135039","journal-title":"Onco Targets Ther"},{"issue":"4","key":"2594_CR101","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2015.03.001","volume":"27","author":"SL Topalian","year":"2015","unstructured":"Topalian SL, Drake CG, Pardoll DM (2015) Immune checkpoint blockade: a common denominator approach to cancer therapy. Cancer Cell 27(4):450\u2013461","journal-title":"Cancer Cell"},{"key":"2594_CR102","doi-asserted-by":"publisher","first-page":"45","DOI":"10.12703\/r\/10-45","volume":"10","author":"D Valdembri","year":"2021","unstructured":"Valdembri D, Serini G (2021) The roles of integrins in cancer. Fac Rev 10:45","journal-title":"Fac Rev"},{"key":"2594_CR103","doi-asserted-by":"publisher","first-page":"382","DOI":"10.3389\/fendo.2020.00382","volume":"11","author":"TY Huang","year":"2020","unstructured":"Huang TY, Wang CY, Chen KY, Huang LT (2020b) Urinary Exosomal thyroglobulin in thyroid Cancer patients with post-ablative therapy: a new biomarker in thyroid Cancer. Front Endocrinol (Lausanne) 11:382","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2594_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0235214","volume":"15","author":"H Zhang","year":"2020","unstructured":"Zhang H, Silva AC, Zhang W, Rutigliano H, Zhou A (2020) Raman spectroscopy characterization extracellular vesicles from bovine placenta and peripheral blood mononuclear cells. PLoS One 15(7):e0235214","journal-title":"PLoS One"},{"issue":"1","key":"2594_CR105","doi-asserted-by":"publisher","first-page":"1568780","DOI":"10.1080\/20013078.2019.1568780","volume":"8","author":"A Gualerzi","year":"2019","unstructured":"Gualerzi A, Kooijmans SAA, Niada S, Picciolini S, Brini AT, Camussi G, Bedoni M (2019) Raman spectroscopy as a quick tool to assess purity of extracellular vesicle preparations and predict their functionality. J Extracell Vesicles 8(1):1568780","journal-title":"J Extracell Vesicles"},{"issue":"4","key":"2594_CR106","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.21873\/invivo.12866","volume":"36","author":"G Geropoulos","year":"2022","unstructured":"Geropoulos G, Psarras K, Papaioannou M, Giannis D, Meitanidou M, Kapriniotis K, Symeonidis N, Pavlidis ET, Pavlidis TE, Sapalidis K, Ahmed NM, Abdel-Aziz TE, Eddama MMR (2022) Circulating microRNAs and clinicopathological findings of papillary thyroid cancer: a systematic review. In Vivo 36(4):1551\u20131569. https:\/\/doi.org\/10.21873\/invivo.12866","journal-title":"In Vivo"},{"issue":"9","key":"2594_CR107","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.annonc.2021.05.806","volume":"32","author":"EA Klein","year":"2021","unstructured":"Klein EA, Richards D, Cohn A, Tummala M, Lapham R, Cosgrove D et al (2021) Clinical validation of a targeted methylation-based multi-cancer early detection test using an independent validation set. Ann Oncol 32(9):1167\u20131177","journal-title":"Ann Oncol"},{"issue":"6","key":"2594_CR108","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1210\/jc.2011-3059","volume":"97","author":"S Yu","year":"2012","unstructured":"Yu S, Liu Y, Wang J, Guo Z, Zhang Q, Yu F et al (2012) Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 97(6):2084\u20132092","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"2594_CR109","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12967-023-03960-8","volume":"21","author":"S Connal","year":"2023","unstructured":"Connal S, Cameron JM, Sala A, Brennan PM, Palmer DS, Palmer JD et al (2023) Liquid biopsies: the future of cancer early detection. J Transl Med 21(1):118","journal-title":"J Transl Med"},{"key":"2594_CR110","doi-asserted-by":"publisher","unstructured":"Irmer B, Chandrabalan S, Maas L, Bleckmann A, Menck K (2023) Extracellular vesicles in liquid biopsies as biomarkers for solid tumors. Cancers (Basel) 15(4):1307. https:\/\/doi.org\/10.3390\/cancers15041307","DOI":"10.3390\/cancers15041307"},{"issue":"48","key":"2594_CR111","doi-asserted-by":"publisher","first-page":"83745","DOI":"10.18632\/oncotarget.19407","volume":"8","author":"B Yu","year":"2017","unstructured":"Yu B, Du Q, Li H, Liu HY, Ye X, Zhu B et al (2017) Diagnostic potential of serum exosomal colorectal neoplasia differentially expressed long non-coding RNA (CRNDE-p) and microRNA-217 expression in colorectal carcinoma. Oncotarget 8(48):83745\u201383753","journal-title":"Oncotarget"},{"issue":"6","key":"2594_CR112","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.eururo.2018.08.019","volume":"74","author":"J McKiernan","year":"2018","unstructured":"McKiernan J, Donovan MJ, Margolis E, Partin A, Carter B, Brown G et al (2018) A prospective adaptive utility trial to validate performance of a novel urine exosome gene expression assay to predict high-grade prostate Cancer in patients with prostate-specific antigen 2-10ng\/ml at initial biopsy. Eur Urol 74(6):731\u2013738","journal-title":"Eur Urol"},{"key":"2594_CR113","doi-asserted-by":"publisher","unstructured":"Sidhom K, Obi PO, Saleem A (2020) A review of Exosomal isolation methods: is size exclusion chromatography the best option? Int J Mol Sci 21(18):6466. https:\/\/doi.org\/10.3390\/ijms21186466","DOI":"10.3390\/ijms21186466"},{"key":"2594_CR114","doi-asserted-by":"publisher","unstructured":"Royo F, Th\u00e9ry C, Falc\u00f3n-P\u00e9rez JM, Nieuwland R, Witwer KW (2020) Methods for separation and characterization of extracellular vesicles: results of a worldwide survey performed by the ISEV rigor and standardization subcommittee. Cells 9(9):Article 1956. https:\/\/doi.org\/10.3390\/cells9091955","DOI":"10.3390\/cells9091955"},{"issue":"1","key":"2594_CR115","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1038\/s41598-020-57497-7","volume":"10","author":"K Brennan","year":"2020","unstructured":"Brennan K, Martin K, FitzGerald SP, O'Sullivan J, Wu Y, Blanco A et al (2020) A comparison of methods for the isolation and separation of extracellular vesicles from protein and lipid particles in human serum. Sci Rep 10(1):1039","journal-title":"Sci Rep"},{"issue":"14","key":"2594_CR116","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1093\/jnci\/93.14.1054","volume":"93","author":"MS Pepe","year":"2001","unstructured":"Pepe MS, Etzioni R, Feng Z, Potter JD, Thompson ML, Thornquist M et al (2001) Phases of biomarker development for early detection of cancer. J Natl Cancer Inst 93(14):1054\u20131061","journal-title":"J Natl Cancer Inst"},{"issue":"15","key":"2594_CR117","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.7150\/thno.33683","volume":"9","author":"D He","year":"2019","unstructured":"He D, Wang H, Ho SL, Chan HN, Hai L, He X et al (2019) Total internal reflection-based single-vesicle in situ quantitative and stoichiometric analysis of tumor-derived exosomal microRNAs for diagnosis and treatment monitoring. Theranostics 9(15):4494\u20134507","journal-title":"Theranostics"},{"issue":"4","key":"2594_CR118","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.12421","volume":"13","author":"C Pinheiro","year":"2024","unstructured":"Pinheiro C, Guilbert N, Lippens L, Roux Q, Boiy R, Fischer S et al (2024) Identification and validation of extracellular vesicle reference genes for the normalization of RT-qPCR data. J Extracell Vesicles 13(4):e12421","journal-title":"J Extracell Vesicles"},{"issue":"8","key":"2594_CR119","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0183435","volume":"12","author":"T Lange","year":"2017","unstructured":"Lange T, Stracke S, Rettig R, Lendeckel U, Kuhn J, Schl\u00fcter R et al (2017) Identification of miR-16 as an endogenous reference gene for the normalization of urinary exosomal miRNA expression data from CKD patients. PLoS One 12(8):e0183435","journal-title":"PLoS One"},{"key":"2594_CR120","doi-asserted-by":"publisher","unstructured":"Ragni E, Perucca Orfei C, De Luca P, Colombini A, Vigan\u00f2 M, Lugano G et al (2019) Identification of miRNA reference genes in extracellular vesicles from adipose derived mesenchymal stem cells for studying osteoarthritis. Int J Mol Sci 20(5):1108. https:\/\/doi.org\/10.3390\/ijms20051108","DOI":"10.3390\/ijms20051108"},{"issue":"1","key":"2594_CR121","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.jksus.2019.10.006","volume":"32","author":"W Zheng","year":"2020","unstructured":"Zheng W, Yang J, Wang Y, Liu X (2020) Exosomal miRNA-93 and miRNA-205 expression in endometrial cancer. J King Saud Univ-Sci 32(1):1111\u20131115","journal-title":"J King Saud Univ-Sci"},{"key":"2594_CR122","doi-asserted-by":"publisher","unstructured":"Martellucci S, Orefice NS, Angelucci A, Luce A, Caraglia M, Zappavigna S (2020) Extracellular vesicles: new endogenous shuttles for miRNAs in Cancer diagnosis and therapy? Int J Mol Sci 21(18):6486. https:\/\/doi.org\/10.3390\/ijms21186486","DOI":"10.3390\/ijms21186486"},{"issue":"12","key":"2594_CR123","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0262017","volume":"16","author":"J Kim","year":"2021","unstructured":"Kim J, Cho S, Park Y, Lee J, Park J (2021) Evaluation of micro-RNA in extracellular vesicles from blood of patients with prostate cancer. PLoS One 16(12):e0262017","journal-title":"PLoS One"},{"issue":"1","key":"2594_CR124","doi-asserted-by":"publisher","first-page":"5474","DOI":"10.1038\/s41598-017-05777-0","volume":"7","author":"P Perge","year":"2017","unstructured":"Perge P, Butz H, Pezzani R, Bancos I, Nagy Z, P\u00e1l\u00f3czi K et al (2017) Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. Sci Rep 7(1):5474","journal-title":"Sci Rep"},{"issue":"1","key":"2594_CR125","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41598-019-38505-x","volume":"9","author":"M Faraldi","year":"2019","unstructured":"Faraldi M, Gomarasca M, Sansoni V, Perego S, Banfi G, Lombardi G (2019) Normalization strategies differently affect circulating miRNA profile associated with the training status. Sci Rep 9(1):1584","journal-title":"Sci Rep"},{"key":"2594_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2022.101478","volume":"23","author":"E Paterson","year":"2022","unstructured":"Paterson E, Blenkiron C, Danielson K, Henry C (2022) Recommendations for extracellular vesicle miRNA biomarker research in the endometrial cancer context. Transl Oncol 23:101478","journal-title":"Transl Oncol"},{"key":"2594_CR127","doi-asserted-by":"publisher","unstructured":"Mosbach ML, Pfafenrot C, von Strandmann EP, Bindereif A, Preu\u00dfer C (2021) Molecular determinants for RNA release into extracellular vesicles. Cells 10(10):2674. https:\/\/doi.org\/10.3390\/cells10102674","DOI":"10.3390\/cells10102674"},{"issue":"1","key":"2594_CR128","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.bbrc.2014.10.064","volume":"454","author":"M Xiang","year":"2014","unstructured":"Xiang M, Zeng Y, Yang R, Xu H, Chen Z, Zhong J et al (2014) U6 is not a suitable endogenous control for the quantification of circulating microRNAs. Biochem Biophys Res Commun 454(1):210\u2013214","journal-title":"Biochem Biophys Res Commun"},{"key":"2594_CR129","doi-asserted-by":"publisher","DOI":"10.3389\/fbioe.2022.948959","volume":"10","author":"D Xu","year":"2022","unstructured":"Xu D, Di K, Fan B, Wu J, Gu X, Sun Y et al (2022) MicroRNAs in extracellular vesicles: sorting mechanisms, diagnostic value, isolation, and detection technology. Front Bioeng Biotechnol 10:948959","journal-title":"Front Bioeng Biotechnol"},{"key":"2594_CR130","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.911861","volume":"9","author":"X Dai","year":"2022","unstructured":"Dai X, Shen L (2022b) Advances and trends in omics technology development. Front Med 9:911861. https:\/\/doi.org\/10.3389\/fmed.2022.911861","journal-title":"Front Med"},{"issue":"1","key":"2594_CR131","doi-asserted-by":"publisher","first-page":"1816641","DOI":"10.1080\/20013078.2020.1816641","volume":"9","author":"JA Welsh","year":"2020","unstructured":"Welsh JA, van der Pol E, Bettin BA, Carter DRF, Hendrix A, Lenassi M et al (2020a) Towards defining reference materials for measuring extracellular vesicle refractive index, epitope abundance, size and concentration. J Extracell Vesicles 9(1):1816641","journal-title":"J Extracell Vesicles"},{"issue":"1","key":"2594_CR132","doi-asserted-by":"publisher","first-page":"1713526","DOI":"10.1080\/20013078.2020.1713526","volume":"9","author":"JA Welsh","year":"2020","unstructured":"Welsh JA, Van Der Pol E, Arkesteijn GJA, Bremer M, Brisson A, Coumans F et al (2020b) MIFlowCyt-EV: a framework for standardized reporting of extracellular vesicle flow cytometry experiments. J Extracell Vesicles 9(1):1713526","journal-title":"J Extracell Vesicles"},{"issue":"7419","key":"2594_CR133","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nature11556","volume":"490","author":"SC Landis","year":"2012","unstructured":"Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW et al (2012) A call for transparent reporting to optimize the predictive value of preclinical research. Nature 490(7419):187\u2013191","journal-title":"Nature"},{"issue":"2","key":"2594_CR134","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s40618-023-02172-7","volume":"47","author":"ZM Besharat","year":"2024","unstructured":"Besharat ZM, Trocchianesi S, Verrienti A, Ciampi R, Cantara S, Romei C et al (2024) Correction: circulating miR-26b-5p and miR-451a as diagnostic biomarkers in medullary thyroid carcinoma patients. J Endocrinol Investig 47(2):485","journal-title":"J Endocrinol Investig"},{"issue":"Supplement_1","key":"2594_CR135","doi-asserted-by":"publisher","first-page":"A875-A","DOI":"10.1210\/jendso\/bvab048.1788","volume":"5","author":"S Leboulleux","year":"2021","unstructured":"Leboulleux S, Bournaud C, Chougnet CN, Zerdoud S, Catargi BN, Cao CD et al (2021) Estimabl2: is there a need for radioiodine ablation in low risk differentiated thyroid cancer (dtc) patients?: Results from the french randomized phase III prospective trial on 776 patients (NCT 01837745). J Endocr Soc 5(Supplement_1):A875-A","journal-title":"J Endocr Soc"},{"issue":"1","key":"2594_CR136","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s13044-023-00148-6","volume":"16","author":"A Smulever","year":"2023","unstructured":"Smulever A, Pitoia F (2023) Conservative management of low-risk papillary thyroid carcinoma: a review of the active surveillance experience. Thyroid Res 16(1):6","journal-title":"Thyroid Res"},{"issue":"7","key":"2594_CR137","doi-asserted-by":"publisher","first-page":"3112","DOI":"10.1007\/s12325-020-01391-1","volume":"37","author":"A Coca-Pelaz","year":"2020","unstructured":"Coca-Pelaz A, Shah JP, Hernandez-Prera JC, Ghossein RA, Rodrigo JP, Hartl DM et al (2020) Papillary thyroid Cancer-aggressive variants and impact on management: a narrative review. Adv Ther 37(7):3112\u20133128","journal-title":"Adv Ther"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-025-02594-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-025-02594-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T08:02:43Z","timestamp":1764748963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-025-02594-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":137,"journal-issue":{"issue":"11-12","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["2594"],"URL":"https:\/\/doi.org\/10.1007\/s00109-025-02594-1","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable\n                      .","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}